A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
一项随机II期临床试验,研究表观遗传学启动联合卡铂治疗铂耐药复发性卵巢癌的疗效
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-1638
Oza, Amit M; Matulonis, Ursula A; Alvarez Secord, Angeles; Nemunaitis, John; Roman, Lynda D; Blagden, Sarah P; Banerjee, Susana; McGuire, William P; Ghamande, Sharad; Birrer, Michael J; Fleming, Gini F; Markham, Merry Jennifer; Hirte, Hal W; Provencher, Diane M; Basu, Bristi; Kristeleit, Rebecca; Armstrong, Deborah K; Schwartz, Benjamin; Braly, Patricia; Hall, Geoff D; Nephew, Kenneth P; Jueliger, Simone; Oganesian, Aram; Naim, Sue; Hao, Yong; Keer, Harold; Azab, Mohammad; Matei, Daniela